In what scientists claim is a major breakthrough in the fight against Type 1 diabetes, a new treatment has been developed to save the diabetics from the use of insulin injections for a lifetime!

Against the backdrop that the faulty immune system of patients suffering from Type 1 diabetes targets the pancreas, the new treatment – a drug codenamed DiaPep277 – essentially helps block the process that causes the body’s immune system to attack the pancreas in Type 1 diabetes patients.

According to the international team of scientists that developed DiaPep 277, the new treatment will hit the markets within the next three years; and will help prevent the advancement of the Type 1 diabetes in the newly-diagnosed patients, chiefly by stalling the destruction of vital insulin-making cells of the pancreas.

In addition, the new drug will also allow a patient’s body to continue making its own insulin, thereby facilitating the recovery of their pancreas to such an extent that sufficient amounts of insulin is made to fully support the body.

With trials of the new treatment currently underway at 140 centres in the U. K., as well as Europe, North America, South Africa and Israel, Dr. Shlomo Dagan - of Andromeda Biotech in Israel – said: “There is evidence to suggest that using the drug over a period of time, maybe a couple of years, will allow the pancreas to recover enough to make more insulin. In that situation the patient could stop injecting insulin”!